Filter Results: (150) Arrow Down

HealthRemove Health → HealthRemove Health →

Page 1 of 150 Results →

Choosing Passion: A Founder’s Mission to Meet a Need for Obesity Care

Re: Jon M. Jachimowicz

Early in her career Brooke Boyarsky Pratt enjoyed considerable success in roles at McKinsey and Berkadia, a Berkshire Hathaway portfolio company. But a routine visit to the doctor in 2020, where she experienced weight stigma yet again, led her to address the problem of obesity care. Boyarsky Pratt had struggled with her weight since she was young. So when she started Knownwell, an integrated weight and primary care provider that was designed to support people with obesity, it was a huge step for her both personally and professionally. In the spring of 2023, Knownwell opened its first weight-inclusive clinic in the Boston area. But Boyarsky Pratt had to make a fundamental decision on how she wanted to grow the company. Should she grow slowly and build a small footprint of clinics in the Boston area over the next few years? Or should she scale fast to potentially help millions of people across the US? Boyarsky Pratt joins Harvard Business School assistant professor Jon Jachimowicz to discuss what it means to pursue your passion in the case, “Choosing the Course of Passion: Brooke Boyarsky Pratt at Knownwell.”

Can AI Save Physicians from Burnout?

by Susanna Gallani, Lidia Moura, and Katie Sonnefeldt

With many physicians suffering from burnout, artificial intelligence could be a potential solution. Yet if health care payment models continue to push doctors to treat as many patients as possible, AI may inadvertently exacerbate the patient volume problem, say Susanna Gallani, Lidia Moura, and Katie Sonnefeldt.

Forgiving Medical Debt Won't Make Everyone Happier

by Rachel Layne

Medical debt not only hurts credit access, it can also harm one's mental health. But a study by Raymond Kluender finds that forgiving people's bills—even $170 million of debt—doesn't necessarily reduce stress, financial or otherwise.

New Hires Lose Psychological Safety After Year One. How to Fix It.

by Michael Blanding

New hires begin their roles eager to offer ideas. But research by Amy Edmondson shows how they become more reluctant to share over time. She explains how psychological safety erodes on the job and provides advice for strengthening it.

Racial Bias Might Be Infecting Patient Portals. Can AI Help?

by Ben Rand

Doctors and patients turned to virtual communication when the pandemic made in-person appointments risky. But research by Ariel Stern and Mitchell Tang finds that providers' responses can vary depending on a patient's race. Could technology bring more equity to portals?

Slim Chance: Drugs Will Reshape the Weight Loss Industry, But Habit Change Might Be Elusive

by Lane Lambert

Medications such as Ozempic, Wegovy, and Mounjaro have upended a $76 billion industry that has long touted lifestyle shifts as a means to weight loss. Regina Herzlinger says these drugs might bring fast change, especially for busy professionals, but many questions remain unanswered.

What Will It Take to Confront the Invisible Mental Health Crisis in Business?

by Kara Baskin

The pressure to do more, to be more, is fueling its own silent epidemic. Lauren Cohen discusses the common misperceptions that get in the way of supporting employees' well-being, drawing on case studies about people who have been deeply affected by mental illness.

Can Remote Surgeries Digitally Transform Operating Rooms?

Launched in 2016, Proximie was a platform that enabled clinicians, proctors, and medical device company personnel to be virtually present in operating rooms, where they would use mixed reality and digital audio and visual tools to communicate with, mentor, assist, and observe those performing medical procedures. The goal was to improve patient outcomes. The company had grown quickly, and its technology had been used in tens of thousands of procedures in more than 50 countries and 500 hospitals. It had raised close to $50 million in equity financing and was now entering strategic partnerships to broaden its reach. Nadine Hachach-Haram, founder and CEO of Proximie, aspired for Proximie to become a platform that powered every operating room in the world, but she had to carefully consider the company’s partnership and data strategies in order to scale. What approach would position the company best for the next stage of growth? Harvard Business School associate professor Ariel Stern discusses creating value in health care through a digital transformation of operating rooms in her case, “Proximie: Using XR Technology to Create Borderless Operating Rooms.”

Can Business Transform Primary Health Care Across Africa?

Re: Regina E. Herzlinger

mPharma, headquartered in Ghana, is trying to create the largest pan-African health care company. Their mission is to provide primary care and a reliable and fairly priced supply of drugs in the nine African countries where they operate. Co-founder and CEO Gregory Rockson needs to decide which component of strategy to prioritize in the next three years. His options include launching a telemedicine program, expanding his pharmacies across the continent, and creating a new payment program to cover the cost of common medications. Rockson cares deeply about health equity, but his venture capital-financed company also must be profitable. Which option should he focus on expanding? Harvard Business School Professor Regina Herzlinger and case protagonist Gregory Rockson discuss the important role business plays in improving health care in the case, “mPharma: Scaling Access to Affordable Primary Care in Africa.”

Could a Business Model Help Big Pharma Save Lives and Profit?

by Esther Schrader

Gilead Sciences used a novel approach to help Egypt address a public health crisis while sustaining profits from a key product. V. Kasturi Rangan and participants at a recent seminar hosted by the Institute for the Study of Business in Global Society discussed what it would take to apply the model more widely.

This Company Lets Employees Take Charge—Even with Life and Death Decisions

by Annelena Lobb

Dutch home health care organization Buurtzorg avoids middle management positions and instead empowers its nurses to care for patients as they see fit. Tatiana Sandino and Ethan Bernstein explore how removing organizational layers and allowing employees to make decisions can boost performance.

Can Robin Williams’ Son Help Other Families Heal Addiction and Depression?

Re: Lauren H. Cohen

Zak Pym Williams, son of comedian and actor Robin Williams, had seen how mental health challenges, such as addiction and depression, had affected past generations of his family. Williams was diagnosed with generalized anxiety disorder, depression, and post-traumatic stress disorder (PTSD) as a young adult and he wanted to break the cycle for his children. Although his children were still quite young, he began considering proactive strategies that could help his family’s mental health, and he wanted to share that knowledge with other families. But how can Williams help people actually take advantage of those mental health strategies and services? Professor Lauren Cohen discusses his case, “Weapons of Self Destruction: Zak Pym Williams and the Cultivation of Mental Wellness.”

How Martine Rothblatt Started a Company to Save Her Daughter

Re: Debora L. Spar

When serial entrepreneur Martine Rothblatt (founder of Sirius XM) received her seven-year-old daughter’s diagnosis of Pulmonary Arterial Hypertension (PAH), she created United Therapeutics and developed a drug to save her life. When her daughter later needed a lung transplant, Rothblatt decided to take what she saw as the logical next step: manufacturing organs for transplantation. Rothblatt’s entrepreneurial career exemplifies a larger debate around the role of the firm in creating solutions for society’s problems. If companies are uniquely good at innovating, what voice should society have in governing the new technologies that firms create? Harvard Business School professor Debora Spar debates these questions in the case “Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams.” As part of a new first-year MBA course at Harvard Business School, this case examines the central question: what is the social purpose of the firm?

Using Design Thinking to Invent a Low-Cost Prosthesis for Land Mine Victims

Re: Srikant M. Datar

Bhagwan Mahaveer Viklang Sahayata Samiti (BMVSS) is an Indian nonprofit famous for creating low-cost prosthetics, like the Jaipur Foot and the Stanford-Jaipur Knee. Known for its patient-centric culture and its focus on innovation, BMVSS has assisted more than one million people, including many land mine survivors. How can founder D.R. Mehta devise a strategy that will ensure the financial sustainability of BMVSS while sustaining its human impact well into the future? Harvard Business School Dean Srikant Datar discusses the importance of design thinking in ensuring a culture of innovation in his case, “BMVSS: Changing Lives, One Jaipur Limb at a Time.”

Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?

by Kasandra Brabaw

One in 10 people in America lack health insurance, resulting in $40 billion of care that goes unpaid each year. Amitabh Chandra and colleagues say ensuring basic coverage for all residents, as other wealthy nations do, could address the most acute needs and unlock efficiency.

The Power of Personal Connections: How Shared Experiences Boost Performance

by Rachel Layne

Doctors who train together go on to provide better patient care later in their careers. What could teams in other industries learn? Research by Maximilian Pany and J. Michael McWilliams.

COVID-19 Lessons: Social Media Can Nudge More People to Get Vaccinated

by Scott Van Voorhis

Social networks have been criticized for spreading COVID-19 misinformation, but the platforms have also helped public health agencies spread the word on vaccines, says research by Michael Luca and colleagues. What does this mean for the next pandemic?

Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them

by Scott Van Voorhis

Diversifying clinical trials could build trust in new treatments among Black people and their physicians. Research by Joshua Schwartzstein, Marcella Alsan, and colleagues probes the ripple effects of underrepresentation in testing, and offers a call to action for drugmakers.

Curbing an Unlikely Culprit of Rising Drug Prices: Pharmaceutical Donations

by Ben Rand

Policymakers of every leaning have vowed to rein in prescription drug costs, with little success. But research by Leemore Dafny shows how closing a loophole on drugmaker donations could eliminate one driver of rising expenses.

Can Amazon Remake Health Care?

by Christina Pazzanese, Harvard Gazette

Amazon has disrupted everything from grocery shopping to cloud computing, but can it transform health care with its One Medical acquisition? Amitabh Chandra discusses company's track record in health care and the challenges it might face.